These transformed faces of Face-1 HLA-I molecules are indeed novel antigens and serve as the primary targets for passive and active specific immunotherapy of many cancers [135] One such well known novel antigen is O-acetylated sialic acid on gangliosides, which are used as target antigens for an allogenic melanoma vaccine [136,137]. Here, ZMPSTE24 is linked to cancer.